JAMA Editor’s Summary

Tight Glycemic Control and Use of Verapamil in Pediatric Type 1 Diabetes, US Trends in Pediatric Mental Health Hospitalizations, Evaluation for Secondary Hypertension in Children, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 28, 2023, issue. Related Content:

March 28, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Statin Treatment Strategies for Patients With Coronary Artery Disease, Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19, Review of Diagnosis and Treatment of Acute Myocarditis, and more

← Older

Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Tight Glycemic Control and Use of Verapamil in Pediatric Type 1 Diabetes, US Trends in Pediatric Mental Health Hospitalizations, Evaluation for Secondary Hypertension in Children, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 28, 2023, issue.